11/11/2014 - 11:15am

Some experts predicted last year's “polar vortex” would turn into a springtime “pollen vortex.” But the “pollen vortex” didn’t happen — at least not everywhere.

11/11/2014 - 10:01am

Dr. Reddy's Labs received approval from the Food and Drug Administration for a generic version of Roche Holding's antiviral medication Valcyte, according to a Reuters report

11/11/2014 - 8:35am

UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.

11/10/2014 - 5:01pm

Greenstone announced the launch of sirolimus tablets. The product is offered in 1-mg and 2-mg dosage strengths in bottles of 100 tablets each. 

11/10/2014 - 11:40am

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

11/10/2014 - 10:13am

The Centers for Disease Control and Prevention on Friday ordered $2.7 million in personal protective equipment to increase strategic national stockpile supplies to assist U.S. hospitals caring for Ebola patients.

11/10/2014 - 10:01am

Mission Pharmacal Company and Europa Sports Products of Charlotte, N.C., signed an agreement for Europa to distribute Mission's Compete energy bites to fitness centers and select other retail outlets nationally.

 

11/10/2014 - 9:21am

Sandoz last week announced the launch of a generic version of cyclophosphamide injection, USP. Sandoz is launching the drug through collaboration with Jiangsu Hengrui Medicine Co., which owns the product's abbreviated new drug application. 

11/07/2014 - 2:51pm

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.